Press release
Glucosamine Market to Reflect a Holistic Expansion During 2017-2027
Glucosamine Market Introduction:Glucosamine is a naturally occurring compound within the cartilage of joints, it is made from chains of sugars and proteins bound together. Glucosamine is derived from shellfish that has been found to provide relief from minor pain. This naturally derived compound helps in formation of cartilage and synovial fluid which helps in maintaining joint health. Glucosamine is primarily used to ease symptoms of osteoarthritis, it can be taken by natural food supplements such as bone broth or glucosamine supplements available in the market in numerous formulations. Apart from its therapeutic use glucosamine is also used in cosmetic products, as it supports formation of connective tissue and helps increasing moisture and promotes exfoliation and hydration. These fundamental properties of glucosamine have encouraged the manufacturers to introduce new products and thus leading to overall growth of glucosamine market.
Glucosamine Market Segmentation:
Glucosamine is segmented on the basis of form and end use. The use of niacin is not just limited to pharmaceutical product for relief from joint pain but is also used as an ingredient in cosmetics due to its skin-replenishing property and prompting exfoliation. On the basis of form glucosamine is segmented as; powder, liquid, tablets, capsules and others (gel). It is also segmented by end use as pharmaceutical and as additive, which is further sub-segmented as pet-food additive and cosmetics. Glucosamine is suggested for joint problems and is one of the most common dietary supplements for both humans and dogs use. Pet food manufacturers have added glucosamine to provide further joint support especially for older dogs or large breed dogs.
Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3193
Glucosamine Market Regional Outlook:
On the basis of regions, the glucosamine market is very prominent in European countries, as an over-the-counter or prescription medication. Glucosamine is either subsidized or reimbursed by certain insurers or some government health plans which is not the same U.S.
With a higher prevalence of osteoarthritis in developed countries, glucosamine finds a higher recommendations for treatment of Osteoarthritis in European countries as well as U.S., Canada and Australia. Even though high quality studies for glucosamine and its effectiveness still does not hold a strong ground certain consumers have valued glucosamine to be better than other alternatives available which is due to the fact that glucosamine has been found to be as safe as placebo with very few side effects compared to some other pharmaceutical medications for osteoarthritis.
Glucosamine Market Drivers and Trends
Increasing use of glucosamine in pet food; in 2016, Nootie, which is a supplier of health products for pets, launched its new product “Progility” which is a chewable treat for dogs. The product features glucosamine, providing relieve from joint pain and sustaining immune health.
Benyfit Natural which is a raw dog food manufacturer has announced the launch of its Benyfit Mini Range, with added Glucosamine and Chondroitin in the senior dog foods for healthy joints.
Substantial application of glucosamine in cosmetic products; Olay launched eyes illuminating eye cream for dark circles under eyes a range of products for its eye Olay eyes segment. The product features use of amino peptides and N-Acetyl glucosamine for reduction of dark circles.
Continuing use for improving bone health with synergistic compounds; Xango a multilevel marketing company, launched its Aeris marine collagen complex to boost its product portfolio. The product consists of hydrolyzed marine collagen peptides with glucosamine to promote healthy skin, hair, joints and bones.
Visit For TOC@ https://www.futuremarketinsights.com/toc/rep-gb-3193
Glucosamine Market Key Players:
Some of the key players participating in the global Glucosamine market includes; Mylan N.V., Teva Pharmaceutical Industries Ltd., Nutralife Health Products Inc., Blackmores Ltd., G.T.C. Union Group Ltd., Foodchem International Corporation, Health World Ltd., Glanbia plc., NOW Health Group, Inc.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: http.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glucosamine Market to Reflect a Holistic Expansion During 2017-2027 here
News-ID: 954908 • Views: …
More Releases from Future Market Insights
Tumor Profiling Market Size and Share Forecast Outlook From 2025 to 2035
The Tumor Profiling Market is entering a transformative decade, driven by precision oncology, liquid biopsy advancements, advanced sequencing technologies, and growing demand for personalized cancer treatment. As leading companies like Thermo Fisher Scientific, Illumina, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, and Agilent Technologies strengthen their product portfolios, the tumor profiling market is expected to witness sustained adoption across diagnostic laboratories, clinics, and hospitals.
"Explore trends before investing - request a sample…
Personalization Lead the Prescription Lens Market Share Analysis Growth Path
The global Prescription Lens Market Share Analysis is entering a pivotal growth phase as aging populations, digital lifestyles, and advanced vision-care technologies reshape consumer needs. The market is projected to grow at a 3.7% CAGR and reach USD 62,666.2 million by 2035. As demand continues accelerating, leading brands are refining their strategies to serve evolving optical expectations.
"Explore trends before investing - request a sample report today!"
https://www.futuremarketinsights.com/reports/sample/rep-gb-20711
Market Momentum: What Is Powering…
Peptide Microarray Market Growth Outlook to 2035: Innovation, Strategy, and Mark …
The Peptide Microarray Market is entering a transformative phase driven by technology advancements, rising investment in proteomics, and expanding applications across diagnostics and drug discovery. According to projections, the peptide microarray market is set to reach USD 903.8 million by 2025, progressing steadily at a CAGR of 3.8% through 2035. Precision tools, proteomics infrastructure growth, and innovation in peptide profiling platforms continue to reshape the future of global healthcare innovation.
Explore…
Japan Cold Laser Therapy Market Size and Share Forecast Outlook From 2025 to 203 …
The Japan Cold Laser Therapy Market is set for steady expansion as healthcare providers, manufacturers, and end users shift toward advanced non-invasive treatment technologies. The (Japan Cold Laser Therapy Market) is projected to rise from USD 7.2 million in 2025 to USD 12.0 million by 2035, reflecting a CAGR of 5.2%. Cold laser therapy is gaining recognition due to its ability to reduce inflammation, promote healing, and alleviate pain-without requiring…
More Releases for Glucosamine
Track Glucosamine Price Trend Historical and Forecast
Glucosamine Price Trend and Forecast: Global Market Insights, Regional Movements, and Procurement Outlook
Executive Summary
The global Glucosamine market experienced multi-directional price activity across major regions through 2024 and 2025, influenced by shifting procurement cycles, seasonal demand, cost structures, and trade-flow dynamics. While North America showed moderate fluctuations shaped by cautious pharmaceutical and nutraceutical buying, the Asia Pacific (APAC) region registered sharper declines due to inventory-led pressures. Europe, meanwhile, navigated a narrow…
Glucosamine Prices, Pricing Report, Trends, Monitor | IMARC Group
North America Glucosamine Prices the Q4:
Glucosamine Prices in United States:
In United States see, Glucosamine Prices plummeted to about 7,200 USD/MT in December 2024 on global supply chain stabilization and stock building by strategic stockpiling through China's Golden Week. As Chinese exporters drove lower pricing Glucosamine Price Trend reversed to down, U.S. producers reduced their stock positions to more match-market conditions. The market getting softer again as logistics and labor issues…
Glucosamine Prices Influence by Seasonal Demand & Supply Shifts
North America Glucosamine Prices the Q4 2024:
Glucosamine Prices in United States:
In December 2024, Glucosamine prices in the United States saw a notable drop, falling to 7,200 USD/MT. This decline was mainly attributed to strategic stockpiling ahead of China's Golden Week and the stabilization of supply chains. As Chinese exporters began to present more competitive pricing and U.S. suppliers concentrated on lowering their inventory, the market turned more favorable for buyers,…
Glucosamine Market Size, Share, Growth 2031
Glucosamine Market Size was estimated at USD 241.2 million in 2021 and is projected to reach USD 317.4 million by 2028, exhibiting a CAGR of 4% during the forecast period.
The Glucosamine Market 2024 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research…
Global Glucosamine Market Report - Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Glucosamine Market is projected to grow at a CAGR of 3.2% from 2021 to 2026.
The major factors expected to be the drivers of market growth include the increasing number of arthritis patients, boosting desk-bounded working style in developing as well as developed nations, growing prevalence of obesity, and the rising consumption of dietary supplements.
The major…
Glucosamine Market Compute in High Growing Sectors
The global glucosamine market include various different product types such as powder, tablets, capsules and liquids. Glucosamine is naturally synthesized in the human body, used as a health supplement and can be used in the treatment of various conditions such as rheumatoid arthritis, asthma, inflammatory bowel diseases, joint pain, allergies, chronic venous insufficiency, sports injuries, temporomandibular joint problems (TMJ), and long-term low back pain.
Request Free Sample Report of Glucosamine Market…
